US Patent Issued to Agency for Science, Technology and Research on Jan. 28 for "Kit for identifying malignancy, and uses thereof" (Singaporean Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,287, issued on Jan. 28, was assigned to Agency for Science, Technology and Research (Singapore).

"Kit for identifying malignancy, and uses thereof" was invented by Bong Hwa Gan (Nanos, Singapore), Masafumi Inoue (Nanos, Singapore) and Veronica Diermayr (Nanos, Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a multiplexed amplification reaction kit for identifying a subject suffering from a malignancy sensitive to treatment with an inhibitor of the Wnt signaling pathway, comprising a primer pair capable of amplifying a PTPRK(e13)-RSPO3(e2) R-Spondin gene-fusion. Also disclosed is a method of identifying sensit...